Skip to main content
    O

    Olema Pharmaceuticals Inc (OLMA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $7.22
    -0.14 (-1.90%)

    Market Cap: $662.30M

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Olema Pharmaceuticals Inc (OLMA) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Olema Pharmaceuticals (OLMA) has a latest price of $7.22 on Nov 17, 2026, 80.1% below its 52-week high of $36.26. Its price fell 14.0% over the past 12 months. The month-end price fell 74.1% over the 5 years through Oct 2026, a compound annual decline of 23.7%.

    Price Chart

    From Nov 2020 to Oct 2026, its highest month-end close was $51.00 in Nov 2020 and its lowest $2.45 in Dec 2022, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart OLMA with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for OLMA.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 36.2%, and over 6 months it fell 44.9%. The month-end price fell 47.3% over the 3 years through Oct 2026, a compound annual decline of 19.2%.

    PeriodChange
    1 month+1.5%
    3 months-36.2%
    6 months-44.9%
    12 months-14.0%
    12 months, with dividends-14.0%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-47.3%-19.2%
    5 years-74.1%-23.7%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2023, when the price rose 472.7%, and its weakest was 2021, when it fell 80.5%.

    YearCloseChange
    2026 through Oct 2026$7.00-72.0%
    2025$25.00+328.8%
    2024$5.83-58.4%
    2023$14.03+472.7%
    2022$2.45-73.8%
    2021$9.36-80.5%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 10.2% below its 50-day average of $8.04 and 44.0% below its 200-day average of $12.90.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$7.22
    52-week high$36.26-80.1%
    52-week low$6.24+15.7%
    50-day average$8.04-10.2%
    200-day average$12.90-44.0%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 82.1%.

    MeasureValue
    1-year beta1.43
    Largest fall, 1 year-82.1%
    Largest fall, 3 years-82.1%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About OLMA

    What is OLMA's 1-year price change?

    Olema Pharmaceuticals's price fell 14.0% over the past 12 months. With dividends included, the 12-month total return was -14.0%.

    What is OLMA's 5-year price change?

    Olema Pharmaceuticals's month-end price fell 74.1% over the 5 years through Oct 2026, a compound annual decline of 23.7%. These figures leave out dividends.

    What is OLMA's 52-week high and low?

    Olema Pharmaceuticals's 52-week high is $36.26 and its 52-week low is $6.24. Its latest price of $7.22 on Nov 17, 2026 is 80.1% below the high.

    What is OLMA's beta?

    Olema Pharmaceuticals's 1-year beta against the S&P 500 is 1.43, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 82.1%.

    Is the OLMA chart free?

    Yes. Advanced Charting for OLMA is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.